SCHEMBL6478111

SCHEMBL6478111

CCCCOC(=O)c1cn[nH]c1-c1cc2ccccc2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
TSHR P16473 7/20 0.50
KDM4E B2RXH2 4/20 0.50
TDP1 Q9NUW8 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
CYP3A4 P08684 3/20 0.47
CYP1A2 P05177 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPK1 P28482 3/20 0.47
LMNA P02545 2/20 0.47
TP53 P04637 1/20 0.44
HSD17B10 Q99714 2/20 0.43
ITK Q08881 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489610 0.93 KDM4E (0.48) ALDH1A1TSHRKDM4ETDP1L3MBTL1
SCHEMBL5756183 0.89 ALDH1A1 (0.48) ALDH1A1TSHRKDM4EL3MBTL1MAPT
SCHEMBL6488207 0.83 ALDH1A1 (0.49) ALDH1A1TSHRKDM4ETDP1L3MBTL1
SCHEMBL5755243 0.83 ITK (0.46) ALDH1A1TSHRKDM4EL3MBTL1CYP3A4
SCHEMBL5756245 0.80 DRD2 (0.59) ALDH1A1TSHRKDM4EL3MBTL1HPGD
SCHEMBL6478196 0.80 KDM4E (0.55) ALDH1A1KDM4EL3MBTL1CYP1A2MAPT
SCHEMBL5759232 0.78 ITK (0.49) ALDH1A1KDM4EHSD17B10ITKALOX15
SCHEMBL5756565 0.77 ITK (0.46) ALDH1A1KDM4EMAPTMAPK1ITK
SCHEMBL5756205 0.77 KDM4E (0.47) KDM4ETDP1MAPTHPGDHSD17B10
SCHEMBL5754202 0.76 CHEK1 (0.46) KDM4EMAPTHPGDHSD17B10ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 ALDH1A1 2469/4885TSHR 2449/4885KDM4E 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.